Home > Boards > US OTC > Medical - Equipment >

Hypertension Diagnostics, Inc. (HDII)

HDII RSS Feed
Add HDII Price Alert      Hide Sticky   Hide Intro
Moderator: MU_Redskin1, Golden_Cross, RiseandShine, Holdingprofits, AKthisistheone, Cache
Search This Board: 
Last Post: 10/15/2019 12:47:24 AM - Followers: 190 - Board type: Free - Posts Today: 6

Hypertension Diagnostics Inc. Announces to All Shareholders

Wednesday, October 2, 2019 9:55 AM

TORONTO, ON / ACCESSWIRE / October 2, 2019 / There appears to be a control dispute for Hypertension Diagnostics, Inc. (OTC PINK:HDII) involving Mr. Liangjian Peng and another party. HDII's attorney Stephen Mills is currently dealing with the dispute. We believe this matter will be solved very soon. Mr. Peng, CEO of HDII affirms that he is sole officer and only preferred shares holder of HDII. Mr. Peng will travel to China on October 4, 2019, he will visit ShanDong GerPang Healthcare Group to discuss further cooperation between HDII and ShanDong Gerpang Healthcare Group. Thank you for all shareholders support!

About ShanDong GerPang healthcare Group

The main focus of business for the Group includes bio-pharmaceutical R&D, development and sales of medical informatization software, introduction of technology-based medical interventions, as well as the production and sales of medical supplies, dietary supplements, medicines, and medical equipment supplies through a combination of in-house sales and a network of sales agents across China.

About Hypertension Diagnostics Inc.

Hypertension Diagnostics, Inc. is a public company currently trading on the OTC Markets (OTC: HDII). HDII was originally corporate in Minnesota.

*Safe Harbor Statement Information in this press release may contain ‘forward-looking statements.' Statements describing objectives or goals or the Company's future plans are also forward-looking statements and are subject to risks and uncertainties, including the financial performance of the Company and market valuations of its stock, which could cause actual results to differ materially from those anticipated. Forward-looking statements in this news release are made pursuant to the ‘Safe Harbor' provisions of the United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close transactions being contemplated, risks related to sales, acceptance of Hypertension Diagnostics Inc.'s products, increased levels of competition, changes, dependence on intellectual property rights and other risks detailed from time to time in Hypertension Diagnostics Inc. periodic reports filed with the regulatory authorities.

Contact:

Jeff Peng
jeff.torcn.com@gmail.com

SOURCE: Hypertension Diagnostics Inc.

Hypertension Diagnostics Inc.

Share Structure

Market Cap
1,162,918
05/28/2019
Authorized Shares
150,000,000
05/03/2019
Outstanding Shares
136,813,921
05/03/2019

 
Gerpang is looking to merge through HDII  http://www.gerpanghealthcare.com/  





 
Hypertension Diagnostics Inc. Hosts Meetings with ShanDong GerPanghealthcare Group
 
Toronto, August 30, 2019. Mr. Peng Liangjian, Chairman of Hypertension Diagnostics Inc. (HDII), recently hosted a meeting with the founder of ShanDong GerPanghealthcare Group (SD Gerpang), Mr. Fengyou Lu, for discussions regarding a merger with HDII. The meeting was held at the offices of Golden Panegyric Inc. in Toronto, Canada.
Mr. Fengyou Lu advised that his company is interested in accessing the American capital markets, and the two discussed the possibilities of using HDII as a vehicle to bring the China based company to the U.S. based OTC markets.
SD Gerpang has initiated a number of partnerships for projects in biomedicine in Toronto, Montreal, Boston, New York and Connecticut over the last five years, and is looking to establish a broader presence in North America. It currently has four projects in development in North America, including;
· Gene-coated cardiac stent with McGill University, Canada;
· Hepatitis B virus cure vaccine with Yale University;
· Male infertility detection technology at Mount Sinai Hospital, Canada; and
· The American Maiwei Stroke Clearing Project
The two businessmen agreed to continue further detailed discussions regarding a merger, and will advise of further progress as talks continue.
About ShanDong GerPanghealthcare Group
The main focus of business for the Group includes bio-pharmaceutical R&D, development and sales of medical informatization software, introduction of technology-based medical interventions, as well as the production and sales of medical supplies, dietary supplements, medicines, and medical equipment supplies through a combination of in-house sales and a network of sales agents across China.
About Hypertension Diagnostics Inc.
Hypertension Diagnostics, Inc. is a public company currently trading on the OTC Markets (OTC: HDII). HDII was originally corporate in Minnesota .
https://canadagpi.com/blog/post/5d6dea3e67a89045910a3492-Hypertension-Diagnostics-Inc.-Hosts-Meetings-with-ShanDong-GerPanghealthcare-Group?rid=IPCVd-iptHrhfdFnvMQvUgUyOHbnTlQ-%7C%7Ch%7Ct%7Ct%7Cp%7Cs%7C:%7C%2F%7C%2F%7Ci%7Cn%7Cv%7Ce%7Cs%7Ct%7Co%7Cr%7Cs%7Ch%7Cu%7Cb%7C.%7Ca%7Cd%7Cv%7Cf%7Cn%7C.%7Cc%7Co%7Cm%7C%2F%7Cb%7Co%7Ca%7Cr%7Cd%7Cs%7C%2F%7Cr%7Ce%7Ca%7Cd%7C_%7Cm%7Cs%7Cg%7C.%7Ca%7Cs%7Cp%7Cx%7C%3F%7Cm%7Ce%7Cs%7Cs%7Ca%7Cg%7Ce%7C_%7Ci%7Cd%7C%3D%7C1%7C4%7C9%7C4%7C1%7C0%7C4%7C5%7C9%7C
 
About Gerpang

Gengbang Medical Group is an innovative technology-based private enterprise located in the Pharmaceutical Valley Industrial Park of Jinan High-tech Zone. The main business scope of the group includes biomedical research and development, medical information software development and sales, medical high-tech introduction, medical high-quality consumables production. And sales, health care products, pharmaceuticals, medical equipment supplies agents and sales. The company has 220 employees and more than 10 international and national patents. The annual turnover is nearly one billion yuan.
Since its establishment in 2006 , the Group's marketing team has had an 11-year marketing history with annual sales exceeding RMB 300 million. The marketing team specializes in promoting pharmaceutical medical devices and consumables. Representative products: Xintailin, Dangli Ganning Capsule, ganglioside, surgical orthopedic consumables and other products. More than 50 in-service marketing staff , more than 2,000 agents . The marketing department, the commerce department, the training department, and the customer service department are fully equipped and fully functional. The business scope covers more than 20 provinces across the country : Beijing, Shanghai, Zhejiang, Jiangsu, Shandong, Hebei, Henan, Anhui, Hunan, Hubei, Sichuan, Chongqing, Guangdong, Fujian, Liaoning, Heilongjiang, etc., and has more than 1,000 Home hospitals cooperate.
In the past five years, the Group has established strategic partnerships with a number of universities in biomedicine in Toronto, Montreal, Boston, New York and Connecticut, and has established extensive government resource management and business contacts. Relationships have now resulted in multiple levels of investment for more than 20 projects. In Toronto, Montreal and New York, it has invested more than 50 million yuan to screen the world's first-class projects in the biomedical industry.


The four major international projects that have been introduced:
Gene-coated cardiac stent from McGill University, Canada, hepatitis B virus cure vaccine from Yale University, male infertility detection technology at Mount Sinai Hospital, Canada, and the American Maiwei Stroke Clearing Project. The global production bases of the four major projects will be located in the Jinan High-tech Zone. After the project is matured, it will be built in Jinan Pharmaceutical Valley and Life Science City for 5-7 years to build a world-class biomedical industrial park. The park plans to acquire 500 mu of land and gradually establish five multi-functional parks: biomedical incubator and medium Test Base Park; Pharmaceutical Logistics and Pharmaceutical Products Trade Complex; Innovative Medicine and Medical Devices, Consumables and Health Products Industrial Park; International Cardiovascular and Rehabilitation Park; Established Talent Training Base with University of Toronto, Tsinghua University and Shandong University Pharmaceutical Business School Campus.
In October 2015, the first “ China Canada Biomedical New Technology Cooperation Forum ” was held in Jinan, Shandong Province with Harvard University, Massachusetts Institute of Technology, Yale University, University of Michigan, McGill University, University of Toronto, McMahon. The University of Queens, Queen's University, Bethune Medical Development Association and other units have jointly established the China North America Innovation Medical Investment and Industry Alliance , which brings the world's most advanced biomedical technology to China and promotes the national pharmaceutical industry with technological innovation. development of. The forum is held once a year.
In the next five years of development, the group company will be based in Shandong, focus on North America, cooperate in research and development of new technologies from the innovation of the pharmaceutical industry chain, introduce a number of world-class projects, and establish a nationwide Greater China marketing management platform in the distribution agency market. In the hospital terminal market, establish a platform for the professional chain hospital with reasonable technology and reasonable operation.




Liangjian Peng the new CEO of HDII, is the Vice president of Operations for ZMRK and VP of Golden Panegyric

Liangjian Peng :
Ph.D., University of Strathclyde, UK, President of BM Fund Management Ltd., co-founder of Canadian International Television CCCTV, founder of Toronto Online, a number of listed companies and investors in technology projects, received in 2006 in Canada Chinese TV's first "Imperial Immigrant Ambassador" title, in 2008 won the first new immigrant "New Maple" entrepreneurship award of Canada's New Era TV, and served as vice chairman of the Canadian Bethune Medical Foundation, a famous overseas philanthropist, collector, cultural activist and angel Investors. He has made many achievements in the theoretical research and practice of power system automation, artificial intelligence, computer and power system security. Academic articles have been published in IEEE, IEE and "Electricity" professional magazines.
 
“We expect to make major announcements regarding Zalemark, as well as Hypertension Diagnostics, Inc. (OTC: HDII) in the very near future. We have been in advanced discussions with some impressive private companies that are seeking our assistance in achieving public listings in the United States through these vehicles.” 

ZMRK just received the $144M AeroPonLeaf Canada company what impressive company will HDII receive.


This is the website for Golden Panegyric https://canadagpi.com/ The site has to be translated in English you can use google translate.

Taken from the website 
Company Overview

Jinhao is mainly to help small and medium-sized enterprises to quickly list in the major capital markets of the United States, continue to raise funds for rapid development, integrate industries, and build an industrial ecosystem. The strengths of the company include: helping small and medium-sized enterprises to achieve rapid and large-scale financing, helping small and medium-sized enterprises to achieve global operations, and helping small and medium-sized enterprises to become bigger and stronger.




Hanergy does over $2 bil revs a year, and valued at over $30 bil.

Hanergy owns Jinhao Holdings Limited And Jinhao Holdings owns Golden Panegyric Inc.

And that is why David Xu is the CFO of ZMRK Cause David Xu is the CFO of Hanergy.

 


Back to Liangjian Peng the new CEO of HDII we also find him in another filing with Robert Xu and Xao Ming Gong. Xao Ming also owns a company called Sun Bloom Agriculture.

Please note Meihua XU is Roberts Xu's Chinese name





Company Name:   SUNBLOOM AGRICULTURE INC.
 
File Number:   1078192-4
 
Filing Province:   Ontario
 
Filing Status:   Active
 
Filing Date:   May 14, 2018
 
Company Age:   1 Years
 
Principal Address:  
 
 
 
 
 
 
 
 
 
 
5597 19th Avenue
Markham, ON L3P 3J3 CA
Sponsored Links
Company Contacts
HONG YUN ZHANG
 
Director
 
 
2236 Rue Du Général
Terrebonne, QC J6X 4B7 CA
 
XIAO MING GONG
 
Director
 
 
5597 19th Avenue
Markham, ON L3P 3J3 CA
 
View

https://www.bizapedia.com/canada/sunbloom-agriculture-inc.html


*DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.




 
HDII
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
HDII News: Quarterly Report (10-q) 09/19/2019 03:43:23 PM
HDII News: Quarterly Report (10-q) 09/19/2019 11:58:35 AM
HDII News: Annual Report (10-k) 09/18/2019 04:23:48 PM
HDII News: Annual Report (10-k) 09/18/2019 11:45:09 AM
HDII News: CLS Holdings (CLSH) $1.15 Price Target - MASS Approval for Recreational License 09/17/2019 07:17:00 AM
PostSubject
#4648  Sticky Note $HDII Current Filings and Share Structure: Golden_Cross 09/27/19 04:43:46 AM
#3527  Sticky Note Links to some very prestigious companies and our CaptainWeee 09/18/19 02:00:53 PM
#2612  Sticky Note Hypertension Diagnostics Inc. Hosts Meetings with ShanDong GerPanghealthcare Reversemergers 09/04/19 02:32:53 PM
#1864  Sticky Note Is SD Gerpang Biotec Co. Ltd coming to HDII? Holdingprofits 06/26/19 01:25:55 AM
#6034   Looking like it will be a good Christmas CrazyHermit 10/15/19 12:47:24 AM
#6033   looking forward to it buccaneer1961 10/15/19 12:26:51 AM
#6032   It’s about to get serious in here...1st CD armour1955 10/15/19 12:25:58 AM
#6031   good,hopefully they send it to otc tomorrow and buccaneer1961 10/15/19 12:25:32 AM
#6030   Yes per last statement it goes to OTC RiseandShine 10/15/19 12:13:25 AM
#6029   and that one goes to the otc? buccaneer1961 10/15/19 12:07:17 AM
#6028   That is correct he has the doc in hand RiseandShine 10/14/19 11:27:28 PM
#6027   https://twitter.com/LlcBillionaire/status/1183738461918023685/photo/1 buccaneer1961 10/14/19 10:59:25 PM
#6026   Whose twitter Acct? Please post link... armour1955 10/14/19 10:06:21 PM
#6025   Mind posting a link there good buddy?Giving me CrazyHermit 10/14/19 09:06:19 PM
#6024   From twitter: 2manypips 10/14/19 08:31:19 PM
#6023   Agree 100%. All of my ROTH IRA contributions DrewStegman 10/14/19 05:52:20 PM
#6022   Agreed... I am brezlin 10/14/19 05:17:05 PM
#6021   I’m going to continue to add as long dheminger 10/14/19 04:39:02 PM
#6020   I havent. He said the guy would be Martin Riggs 10/14/19 03:54:02 PM
#6019   Have you reached back out today for updates? _Marti_ 10/14/19 03:49:04 PM
#6018   Agree 100%... I see it the same way....all MoreThanReady 10/14/19 01:36:00 PM
#6017   Either flip/short pennies or wait for the big 2manypips 10/14/19 01:32:15 PM
#6016   The way I see it the price should DrewStegman 10/14/19 01:29:25 PM
#6015   Because the price is being controlled for accumulation MoreThanReady 10/14/19 12:58:12 PM
#6014   Really? How can you tell it is insiders buying? OTCWealth101 10/14/19 12:52:17 PM
#6013   The problem is no merger will happen until amc 10/14/19 12:51:56 PM
#6012   Insiders still trying to load shares.....CD must be MoreThanReady 10/14/19 12:35:52 PM
#6011   That is awesome! Drinking champagne to celebrate. People CannabisPower 10/14/19 12:00:20 PM
#6010   Easy for you to say, I am in OTCWealth101 10/14/19 11:52:22 AM
#6008   Turd is tanking lower. Very well expected! CannabisPower 10/14/19 11:39:12 AM
#6007   Taking too long ,looks like it is all OTCWealth101 10/14/19 11:29:54 AM
#6006   I thought we were waiting on them to RiseandShine 10/14/19 11:10:06 AM
#6005   What else could he say? Why don't they OTCWealth101 10/14/19 11:00:10 AM
#6004   The lawyer said the merging company doesn't have RiseandShine 10/14/19 09:44:21 AM
#6003   A merger like this will be well received brezlin 10/14/19 09:20:48 AM
#6002   Good luck all our time is coming! 10baggerinvestor 10/13/19 03:43:45 PM
#6001   Well stated boom time coming! Fai 2 10/13/19 03:09:04 PM
#6000   No it did not DrewStegman 10/13/19 01:48:23 PM
#5999   Ya absolutely. People dpnt realize. They sold prematurely huggies 10/13/19 01:15:02 PM
#5998   Wow! Dont like to get my hopes up Martin Riggs 10/13/19 08:14:51 AM
#5997   PRE$ Market Cap $421m hit high of $6.91 10baggerinvestor 10/13/19 06:40:54 AM
#5996   Did DOL* also have a CD ??? OTCWealth101 10/13/19 02:57:01 AM
#5995   Totally. This has a making of a real huggies 10/12/19 02:31:29 PM
#5994   Impatient day traders will lose big on this DrewStegman 10/12/19 11:47:54 AM
#5993   I agree and we could see it removed CrazyHermit 10/12/19 11:35:53 AM
#5992   It will be fine. The CD takes time Fai 2 10/12/19 11:32:06 AM
#5991   Next week is where the story goes. Either CrazyHermit 10/12/19 11:14:51 AM
#5990   This is going to skyrocket soon DrewStegman 10/12/19 10:40:07 AM
#5989   oh,ok well,whatever is on them hopefully its buccaneer1961 10/11/19 11:55:27 PM
#5988   Smart money loaded here. Upcoming news. CD updates huggies 10/11/19 11:48:57 PM
#5987   That isn't something I asked as I didnt Martin Riggs 10/11/19 11:40:42 PM
#5986   Chart is screaming a bounce to next leg. simon song 10/11/19 11:26:40 PM
#5985   what exactly is in these docs? what do buccaneer1961 10/11/19 11:13:26 PM
#5984   Cool! armour1955 10/11/19 09:10:05 PM
PostSubject